| Name | Title | Contact Details |
|---|
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
Hannibal Regional Hospital Foundation is a non-profit corporation (501,(c)3) and a part of the Hannibal Regional Healthcare System which exists to support Hannibal Regional Hospital by raising privately donated money.
Adheris is a Burlington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Innovatient helps healthcare organizations deliver better care through an interactive patient experience and engagement technology platform. The highly customizable software provides an easy-to-use solution delivered via TV, tablet, or bedside monitor engaging patients during treatment and after they go home, fostering an environment of wellness and improved outcomes. Our integrated nurse rounding, communication, and patient education tools result in improved patient satisfaction scores (HCAHPS) transforming the patient experience creating long-term relationships with healthcare providers.
Eagle Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing injectable products, primarily in the critical care and oncology areas, using the 505(b)(2) regulatory pathway.